Filtered By:
Specialty: Anesthesiology
Infectious Disease: Common Cold
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia
ConclusionMirogabalin was generally safe, well tolerated, and effective for treatment of CNeP in this long-term study.Trial registrationClinicalTrials.gov identifier, NCT03901352.
Source: Pain and Therapy - April 28, 2023 Category: Anesthesiology Source Type: research
